De Burlo Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-8,390	Closed	-$8.82M	–	82
2024 Q3	$8.82M	Sell	8,390 -300	-3%	-$334K	1.09%	26
2024 Q2	$9.13M	Buy	8,690 +600	+7%	+$582K	1.23%	26
2024 Q1	$7.79M	Buy	+8,090	New	+$7.69M	1.03%	28
2023 Q2	–	Sell	-20,590	Closed	-$16.9M	–	91
2023 Q1	$16.9M	Buy	20,590 +8,900	+76%	+$6.71M	3.3%	7
2022 Q4	$8.43M	Hold	11,690	–	–	1.88%	21
2022 Q3	$8.05M	Buy	+11,690	New	+$7.36M	1.92%	18
2022 Q2	–	Sell	-26,190	Closed	-$18.3M	–	178
2022 Q1	$18.3M	Buy	26,190 +13,600	+108%	+$8.6M	3.41%	9
2021 Q4	$7.95M	Sell	12,590 -6,610	-34%	-$4.06M	1.15%	31
2021 Q3	$11.6M	Buy	+19,200	New	+$11.9M	1.88%	18
2020 Q4	–	Sell	-4,750	Closed	-$2.66M	–	94
2020 Q3	$2.66M	Buy	+4,750	New	+$2.88M	0.48%	46
2019 Q2	–	Sell	-18,200	Closed	-$7.47M	–	94
2019 Q1	$7.47M	Buy	+18,200	New	+$7.49M	1.51%	29
2016 Q1	–	Sell	-11,550	Closed	-$6.27M	–	100
2015 Q4	$6.27M	Buy	11,550 +1,500	+15%	+$813K	1.48%	32
2015 Q3	$4.67M	Buy	+10,050	New	+$5.4M	1.1%	44